Search

everythinglearnresearchcommunity

for

Search:↓

More severe hair loss worsens quality of life in men.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Baldness does not affect vitamin D levels in men.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Family history and elevated DHEA-S levels are linked to more severe hair loss.

Hormone treatment caused hair loss, finasteride helped regrowth.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.

Androgenetic alopecia is linked to family history and androgen effects.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

A man developed hair loss from testosterone treatment but improved with additional medication.

Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Certain Prakruti types are more prone to early male pattern baldness.

Different stages and types of female hair loss are linked with age, menopause, high blood pressure, and skin conditions like acne and hirsutism.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Male pattern hair loss is diagnosed and treated earlier and is milder, possibly due to early puberty.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

Scalp reduction can improve hair distribution in certain baldness cases but requires careful patient selection and understanding of facial structure.

UC-MSCs derived secretome therapy may help treat hair loss safely.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Young people with mild hair loss may experience it due to social stress.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

Dr. Muhammad Ahmad created a simpler system to better describe male pattern hair loss.

The new treatment was safe and may effectively treat male pattern hair loss.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

Hair transplants improve hairlines and reduce distress from hair loss.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.